| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 178.04▲ | 178.37▼ | 178.67▼ | 179.29▼ | 180.18▼ |
| MA10 | 177.97▲ | 178.37▼ | 178.04▲ | 185.47▼ | 169.91▲ |
| MA20 | 178.16▲ | 177.69▲ | 178.75▼ | 180.23▼ | 164.72▲ |
| MA50 | 178.32▼ | 179.24▼ | 185.23▼ | 167.62▲ | 159.93▲ |
| MA100 | 178.03▲ | 186.02▼ | 184.23▼ | 162.75▲ | 189.77▼ |
| MA200 | 178.57▼ | 183.36▼ | 174.94▲ | 154.86▲ | 207.72▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.021▲ | 0.199▲ | 0.452▲ | -1.578▼ | 3.061▲ |
| RSI | 50.181▲ | 47.872▼ | 40.903▼ | 51.613▲ | 55.368▲ |
| STOCH | 47.268 | 70.814 | 73.051 | 25.774 | 77.252 |
| WILL %R | -30.952 | -35.377 | -37.657 | -77.440▼ | -38.664 |
| CCI | 39.987 | 3.208 | -4.763 | -69.194 | 73.690 |
|
Monday, November 03, 2025 07:27 PM
Lab services company Charles River Laboratories (NYSE:CRL) will be announcing earnings results this Wednesday before market hours. Here’s what you need to know.
|
|
Monday, November 03, 2025 01:51 PM
Publication highlights Deramiocel’s anti-fibrotic activity and describes a validated potency assay supporting quality control and product consistency in late-stage development– SAN DIEGO, Nov. 03, ...
|
|
Monday, November 03, 2025 06:39 AM
In the United States, ONS-5010/LYTENAVA™ (bevacizumab-vikg) is investigational. If approved in the United States, ONS-5010/LYTENAVA™, would be the first approved ophthalmic formulation of bevacizumab ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 04/11/25 | 176.50 | 179.74 | 175.50 | 178.24 | 357,020 |
| 03/11/25 | 178.46 | 178.94 | 173.89 | 178.86 | 670,700 |
| 31/10/25 | 178.39 | 181.56 | 178.17 | 180.07 | 950,200 |
| 30/10/25 | 177.12 | 182.06 | 177.12 | 179.11 | 784,700 |
| 29/10/25 | 186.71 | 191.41 | 175.58 | 180.15 | 1,590,700 |
| 28/10/25 | 193.45 | 193.465 | 187.03 | 187.93 | 1,102,933 |
| 27/10/25 | 197.24 | 198.00 | 193.41 | 195.28 | 936,900 |
| 24/10/25 | 194.11 | 199.66 | 191.48 | 197.04 | 1,741,700 |
| 23/10/25 | 191.00 | 195.25 | 188.97 | 190.97 | 1,075,600 |
| 22/10/25 | 190.69 | 190.69 | 184.88 | 187.00 | 1,376,800 |
|
|
||||
|
|
||||
|
|